Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,686.0
33.1 (1.25%)

 

  • STI Straits Times Index
    2,686.0
    33.1 (1.25%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,571.6
    18.9 (1.22%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,226.4
    853.3 (3.36%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,324.4
    171.6 (5.44%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,714.4
    408.0 (1.83%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,995.2
    21.5 (0.43%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 935.5M
  • Value: 614.1M
  • Rise: 227
  • Fall: 73
  • Unch: 508

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Singapore-eDev0.120+0.005
Rex Intl0.186+0.006
Medtecs Intl0.595+0.095
LionGold0.002-
Yoma Strategic0.320+0.005
Synagie0.197+0.006
Spackman0.010-
ThaiBev0.715+0.020
MDR0.001-
AnAn Intl0.070+0.006

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,253.8 -296.2
HSCEI 9,745.8 -107.4
Jakarta 4,863.1 -41.0
Nikkei 225 22,064.8 -447.3
SSE Comp 2,959.0 -11.7
Shanghai A 3,101.5 -12.2
Shanghai B 211.6 -1.8
KOSPI 2,100.4 -34.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

GLAUKOS CORPORATION GLAUKOS CORP
Updated on 02 Jul 2020 (End of trading day)
Last (USD): 38.640 Change: -0.130 High: 39.630 Remarks: -
Change (%): -0.34 Low: 38.550
Open 39.630 Yesterday's Close 38.77
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 403,752 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a 0.34872 Trailing EPS (USD) e -0.84313 NAV (USD) b 14.4991
PE a 110.805 Trailing PE f - Price / NAV b 2.6650
Dividend (USD) d - Cash In Hand (USD) g 1.2122 Issued & Paid-up Shares c 44,230,300
Dividend Yield (%) d - Price / Cash In Hand g 31.876 Treasury Shares h 28,000
Market Cap (M) 1,709.059 Enterprise Value (M) 1,620.667
Piotroski F Score 3 Exchange Code GKOS Par Value ( $ ) n.a.
52 Weeks Volatility (%) 87.75 Free Float (%) 95.5
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 11 May 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 04 Sep 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference GLAUKOS CORPORATION NYSE 1,709.059 110.805 - 2.6650 -
Industry Medical Specialties NYSE 29,293.643 33.989 35.536 3.9852 0.851
Local Peer ABBOTT LABORATORIES NYSE 163,141.035 44.501 46.098 5.3988 1.426
Local Peer THERMO FISHER SCIENTIFIC INC NYSE 144,508.621 39.099 39.386 5.0600 0.210
Local Peer DANAHER CORP NYSE 127,293.757 51.147 46.508 4.3216 0.372
Local Peer MEDTRONIC PLC NYSE 124,955.508 26.092 26.092 2.4628 2.318
Local Peer BECTON DICKINSON & CO NYSE 69,460.859 64.197 76.331 3.3157 1.199
Local Peer STRYKER CORP NYSE 68,945.862 33.099 31.860 5.2570 1.160
Local Peer BOSTON SCIENTIFIC CORP NYSE 50,548.467 10.755 11.791 3.6619 -
Local Peer BAXTER INTERNATIONAL INC NYSE 44,375.588 44.331 43.463 5.7638 0.970
Local Peer EDWARDS LIFESCIENCES CORP NYSE 42,874.552 40.954 38.702 10.9904 -
Local Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 42,666.250 32.665 32.665 3.0174 1.923
Local Peer ALCON AG NYSE 28,902.126 - - 1.5076 -
Local Peer RESMED INC NYSE 27,845.697 68.824 54.319 12.3406 0.764
Other Local Peers ZIMMER BIOMET HOLDINGS INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), TELEFLEX INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), COOPER COS INC (NYSE), BIO RAD LABORATORIES INC (NYSE), STERIS PLC (NYSE), WATERS CORP (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), PERKINELMER INC (NYSE), QIAGEN NV (NYSE), HILL-ROM HOLDINGS INC (NYSE), PENUMBRA INC (NYSE), GLOBUS MED INC (NYSE), HAEMONETICS CORP (NYSE), NEVRO CORP (NYSE), ENVISTA HOLDINGS CORPORATION (NYSE), INSPIRE MEDICAL SYSTEMS INC (NYSE), CONMED CORP (NYSE), CANTEL MEDICAL CORP (NYSE), AVANOS MEDICAL INC (NYSE), VAPOTHERM INC (NYSE), CRYOLIFE INC (NYSE), INVACARE CORP (NYSE), RA MEDICAL SYSTEMS INC (NYSE)
Global Peer INTUITIVE SURGICAL INC NASDAQ 67,694.417 49.079 48.831 7.9578 -
Global Peer DEXCOM INC NASDAQ 37,598.405 371.894 254.215 40.2337 -
Global Peer IDEXX LABORATORIES INC NASDAQ 28,432.171 66.474 65.082 264.0480 -
Global Peer ALIGN TECHNOLOGY INC NASDAQ 22,048.099 49.795 11.671 7.7281 -
Global Peer GENMAB AS SPON ADS EACH REP 0.1 ORD SHS NASDAQ 21,829.665 67.230 164.819 10.3111 -
Global Peer HOLOGIC INC NASDAQ 14,939.799 - 24.245 7.1616 -
Global Peer INSULET CORPORATION NASDAQ 13,235.049 1,140.920 2,567.918 224.3279 -
Global Peer FISHER & PAYKEL HEALTHCARE CORP ASX 18,908.503 69.265 69.265 20.0463 -
Global Peer HARTA Bursa 57,325.062 131.848 131.848 22.5600 -
Global Peer MASIMO CORPORATION NASDAQ 12,539.620 63.907 59.331 10.0054 -
Other Global Peers ABIOMED INC (NASDAQ), TOPGLOV (Bursa), Top Glove (SGX), WEIGAO GROUP (HKEx), DENTSPLY SIRONA INC (NASDAQ), QUIDEL CORP (NASDAQ), COCHLEAR LTD (ASX), MICROPORT (HKEx), BRUKER CORPORATION (NASDAQ), NOVOCURE LTD (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), KANGJI MEDICAL (HKEx), VENUS MEDTECH-B (HKEx), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), NEOGEN CORP (NASDAQ), AK MEDICAL (HKEx), ICU MEDICAL INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), NUVASIVE INC (NASDAQ), SUPERMX (Bursa), PEIJIA-B (HKEx), STAAR SURGICAL CO (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), LIVANOVA PLC (NASDAQ), INARI MEDICAL INC (NASDAQ), EBOS GROUP (ASX), ATRICURE INC (NASDAQ), CAREDX INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), BIOTELEMETRY INC (NASDAQ), KDL MEDICAL (HKEx), AXONICS MODULATION TECHNLOGS INC (NASDAQ), NANOSONICS LIMITED (ASX), SILK ROAD MEDICAL INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), LIFETECH SCI (HKEx), ATRION CORP (NASDAQ), CERUS CORP (NASDAQ), MESA LABORATORIES INC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), INMODE LTD (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), CIRC (HKEx), ACCELERATE DIAGNOSTICS INC (NASDAQ), HESKA CORP (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), ZYNEX INC (NASDAQ), INOGEN INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), VERICEL CORP (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), QUOTIENT LTD (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SURMODICS INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), TRANSMEDICS GROUP INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SI BONE INC (NASDAQ), AXOGEN INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), YESTAR HEALTH (HKEx), CORMEDIX INC (NYSE American), CYTOSORBENTS CORP (NASDAQ), VIEWRAY INC (NASDAQ), PW MEDTECH (HKEx), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), MEDICAL DEVELOPMENT INTL (ASX), ALPHATEC HLDGS INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), STEREOTAXIS INC (NYSE American), GOLDEN MEDITECH (HKEx), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), IRADIMED CORP (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), PROFOUND MED CORP (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), ALPHA PRO TECH (NYSE American), MISONIX INC (NASDAQ), RTI SURGICAL HOLDINGS INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), CUTERA INC (NASDAQ), DERMTECH INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), SIENTRA INC (NASDAQ), Medtecs Intl (SGX), TELA BIO INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), UG Healthcare (SGX), APYX MEDICAL CORPORATION (NASDAQ), MODERN DENTAL (HKEx), NEMAURA MEDICAL INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), VINCENT MED (HKEx), SOLITON INC (NASDAQ), FONAR CORP (NASDAQ), CELSION CORPORATION (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), ELECTROMED INC (NYSE American), BELLEROPHON THERAPEUTICS INC (NASDAQ), INTRICOM CORP (NASDAQ), VENUS CONCEPT INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), PAVMED INC (NASDAQ), BIOMERICA INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), CYCLOPHARM LIMITED (ASX), SOMNOMED LIMITED (ASX), EMVISION MEDICAL DEVICES LTD (ASX), NEPHROS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), NOVA EYE MEDICAL LIMITED (ASX), YUNNAN ENERGY (HKEx), DAXOR CORP (NYSE American), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), LKL (Bursa), Biolidics (SGX), SDI LTD (ASX), CLEARPOINT NEURO INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), CONFORMIS INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), IMPEDIMED LIMITED (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), DIMERIX LTD (ASX), SENSUS HEALTHCARE INC (NASDAQ), ONCOCYTE CORP (NYSE American), COMPUMEDICS (ASX), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), RESONANCE HEALTH LTD (ASX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), KELFRED (HKEx), ZOSANO PHARMA CORP (NASDAQ), RESPIRI LTD (ASX), MOTUS GI HOLDINGS INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), IMMUCELL CORP (NASDAQ), NEOVASC INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), NEURONETICS INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), OVENTUS MEDICAL LTD (ASX), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), Yunnan Energy (SGX), MICRO-X LTD (ASX), ELECTROCORE INC (NASDAQ), LBT INNOVATIONS LTD (ASX), IRIDEX CORP (NASDAQ), IMPRESSION HEALTHCARE LIMITED (ASX), METALICITY LIMITED (ASX), NEUROTROPE INC (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), USCOM LTD (ASX), DARIOHEALTH CORP (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), LIFE HEALTHCARE (HKEx), MYOS RENS TECHNOLOGY INC (NASDAQ), BIOLASE INC (NASDAQ), CHF SOLUTIONS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), AETHLON MEDICAL INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), IMAGION BIOSYSTEMS LIMITED (ASX), PREDICTIVE ONCOLOGY INC (NASDAQ), CHECK-CAP LTD (NASDAQ), AVINGER INC (NASDAQ), ENDOLOGIX INC (NASDAQ), CYANOTECH CORP (NASDAQ), OPTISCAN IMAGING (ASX), DIGIRAD CORP (NASDAQ), CARDIEX LTD (ASX), DYNATRONICS CORP (NASDAQ), Annica (SGX), ADHERIUM LIMITED (ASX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), CANCER GENETICS INC (NASDAQ), ANALYTICA (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), DORSAVI LTD (ASX), NEUROMETRIX INC (NASDAQ), HUAKANG BIOMED (HKEx), OBALON THERAPEUTICS INC (NASDAQ), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.460
+1.20 %
10 Days --2.610
-6.33 %
20 Days --4.510
-10.45 %
Medium Term Return 3 Months -+8.390
+27.74 %
6 Months --16.660
-30.13 %
1 Year --38.160
-49.69 %
Long Term Return 2 Years --4.160
-9.72 %
3 Years --1.590
-3.95 %
5 Years -+8.640
+28.80 %
Annualised Return Annualised --
+5.19 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 23.310 - 84.650 Change From 1 Year Low +15.330 % Change From 1 Year Low (%) +65.77
Change From 1 Year High -46.010 % Change From 1 Year High (%) -54.35
2 Years Range 23.310 - 84.650 Change From 2 Years Low +15.330 % Change From 2 Years Low (%) +65.77
Change From 2 Years High -46.010 % Change From 2 Years High (%) -54.35
5 Years Range 14.250 - 84.650 Change From 5 Years Low +24.390 % Change From 5 Years Low (%) +171.16
Change From 5 Years High -46.010 % Change From 5 Years High (%) -54.35
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard Hill on July 14, 1998 and is headquartered in San Clemente, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
02 Jul 2020 39.630 39.630 38.550 38.640 403,752 -
01 Jul 2020 38.520 39.350 38.260 38.770 285,360 -
30 Jun 2020 37.940 38.730 37.795 38.420 479,570 -
29 Jun 2020 37.180 38.390 36.610 38.180 255,403 -
26 Jun 2020 37.470 37.740 36.770 36.890 1,008,441 -
25 Jun 2020 38.540 39.050 37.130 37.660 615,744 -
24 Jun 2020 40.160 40.250 38.165 38.730 484,092 -
23 Jun 2020 41.650 41.940 40.550 40.760 450,834 -
22 Jun 2020 40.130 41.320 39.910 41.250 516,923 -
19 Jun 2020 40.430 41.540 39.890 40.440 829,111 -
18 Jun 2020 39.340 40.031 39.340 39.940 424,552 -
17 Jun 2020 40.250 41.070 39.380 39.870 441,044 -
16 Jun 2020 41.500 41.890 39.330 39.890 639,928 -
15 Jun 2020 37.110 40.520 37.010 39.800 708,117 -
12 Jun 2020 39.260 39.750 36.750 38.640 756,781 -
11 Jun 2020 37.970 38.800 36.340 37.600 1,039,688 -
10 Jun 2020 40.450 41.380 39.260 39.350 793,931 -
09 Jun 2020 42.230 42.370 40.500 40.730 2,111,431 -
08 Jun 2020 46.440 46.855 42.650 43.150 2,107,647 -
05 Jun 2020 44.040 47.820 43.380 46.830 697,732 -
04 Jun 2020 44.630 44.630 42.430 42.720 585,726 -
03 Jun 2020 41.840 45.365 41.664 44.870 927,306 -
Summary
Current 2 Weeks
(19 Jun 2020 to 02 Jul 2020)
40.430 41.940 36.610 38.640 5,329,230 -
Previous 2 Weeks
(05 Jun 2020 to 18 Jun 2020)
44.040 47.820 36.610 39.940 9,720,851 -
4 Weeks from
(07 May 2020 to 04 Jun 2020)
42.180 42.610 36.610 42.720 13,550,419 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.